PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brmedjLink to Publisher's site
 
Br Med J. 1969 December 27; 4(5686): 764–768.
PMCID: PMC1630282

Steady-state plasma levels of nortriptyline in twins: Influence of genetic factors and drug therapy

Abstract

Nineteen identical (monozygotic) and 20 fraternal (dizygotic) sets of twins between 45 and 51 years of age were given nortriptyline orally in doses of 0·2 mg./kg. body weight three times daily for eight days. The steady-state plasma concentrations of nortriptyline were calculated from the mean of the determinations for days 6, 7, and 8. Identical twins, not treated with other drugs, achieved similar steady-state plasma concentrations of nortriptyline in contrast to fraternal twins who were not given other drugs. The intrapair similarity in steady-state plasma concentrations was not found in identical twins simultaneously treated with various drugs during the experiment. Identical and fraternal twins treated with drugs containing barbiturates had considerably lower steady-state plasma concentrations of nortriptyline compared with untreated twins.

It is concluded that most of the variability in nor-triptyline steady-state plasma concentration between persons who have not received drugs is genetically determined. Exposure to other drugs also influences the steady-state plasma concentration of nortriptyline, which in a given patient may therefore be determined by a resultant of genetic and environmental factors.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • BERNHARD K, BEER H. [Activity of expired carbon dioxide, CNS and other organs after the administration of C14-labelled N-(gamma-dimethyl-aminopropyl)-iminodibenzyl (psychopharmacological drug Tofranil) to rats and dogs]. Helv Physiol Pharmacol Acta. 1962;20:114–121. [PubMed]
  • Brodie BB, Reid WD. Some pharmacological consequences of species variation in rates of metabolism. Fed Proc. 1967 Jul-Aug;26(4):1062–1070. [PubMed]
  • Burns JJ, Conney AH. Enzyme stimulation and inhibition in the metabolism of drugs. Proc R Soc Med. 1965 Nov;58(11 Pt 2):955–960. [PubMed]
  • Hammer W, Sjöqvist F. Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds. Life Sci. 1967 Sep 1;6(17):1895–1903. [PubMed]
  • HERRMANN B. QUANTITATIVE METHODEN ZUR UNTERSUCHUNG DES STOFFWECHSELS VON TOFRANIL. Helv Physiol Pharmacol Acta. 1963;21:402–408. [PubMed]
  • Kolmodin B, Azarnoff DL, Sjöqvist F. Effect of environmental factors on drug metabolism: decreased plasma half-life of antipyrine in workers exposed to chlorinated hydrocarbon insecticides. Clin Pharmacol Ther. 1969 Sep-Oct;10(5):638–642. [PubMed]
  • Levi AJ, Sherlock S, Walker D. Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet. 1968 Jun 15;1(7555):1275–1279. [PubMed]
  • MCMAHON RE, MARSHALL FJ, CULP HW, MILLER WM. THE METABOLISM OF NORTRIPTYLINE-N-METHYL-14C IN RATS. Biochem Pharmacol. 1963 Oct;12:1207–1217. [PubMed]
  • van Rossum JM. Pharmacokinetics of accumulation. J Pharm Sci. 1968 Dec;57(12):2162–2165. [PubMed]
  • van Rossum JM, Tomey AH. Rate of accumulation and plateau plasma concentration of drugs after chronic medication. J Pharm Pharmacol. 1968 May;20(5):390–392. [PubMed]
  • Vesell ES, Page JG. Genetic control of drug levels in man: phenylbutazone. Science. 1968 Mar 29;159(3822):1479–1480. [PubMed]
  • Vesell ES, Page JG. Genetic control of dicumarol levels in man. J Clin Invest. 1968 Dec;47(12):2657–2663. [PMC free article] [PubMed]
  • Vesell ES, Page JG. Genetic control of drug levels in man: antipyrine. Science. 1968 Jul 5;161(3836):72–73. [PubMed]
  • YATES CM, TODRICK A, TAIT AC. Aspects of the clinical chemistry of desmethylimipramine in man. J Pharm Pharmacol. 1963 Jul;15:432–439. [PubMed]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group